Locations

Our
Locations

Immatics operates as a transatlantic organization with the team spanning from Tübingen and Munich, Germany to Houston, Texas. The long-term integration of the European and US sites also brings the advantage that Immatics has built a highly functioning team across two continents with access to two important markets for medical innovation.

Since its foundation in 2000 as a spin out from H.G. Rammensee’s laboratory at University of Tübingen, Germany, Immatics has revolutionized the identification of tumor-associated pHLA targets, which are recognized by T cells. Identifying true cancer targets that are presented on tumor tissue but not on healthy cells and the subsequent discovery, selection, and engineering of a therapeutic TCR are central to Immatics‘ mission: Delivering the power of T cells to cancer patients and advance the next wave in cancer immunotherapy.

In 2015, Immatics and MD Anderson Cancer Center launched Immatics US, Inc. in Houston, Texas as a joint venture to develop transformative Adoptive Cell Therapies.

Immatics US, Inc.

2201 West Holcombe Blvd., Suite 205, Houston, Texas 77030

Business line: +1 346 204-5400, Fax line: +1 346 204-5931
E-Mail: info@immatics.com

Immatics Biotechnologies GmbH

Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany

Phone: +49 7071 5397-0, Fax: +49 7071 5397-900
E-Mail: info@immatics.com

Immatics Biotechnologies GmbH

Machtlfinger Str. 11, 81379 Munich, Germany

Phone: +49 89 540415-0, Fax: +49 89 540415-905
E-Mail: info@immatics.com

Our
Locations